Peregrine Pharmaceuticals Granted Key European Patent for Its Lead Clinical Drug Candidate Bavituximab
June 25, 2015 at 08:30 AM EDT
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) (Nasdaq: PPHMP), a biopharmaceutical company focused on developing novel investigational ...